IRIS Accounts Production v25.4.0.155 11674155 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false false true false Ordinary A 1.00000 Ordinary B 1.00000 15111 3518 26668 115799 16903 97170 24876 15111 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 11674155 2023-12-31 11674155 2024-12-31 11674155 2024-01-01 2024-12-31 11674155 2022-12-31 11674155 2023-01-01 2023-12-31 11674155 2023-12-31 11674155 ns15:EnglandWales 2024-01-01 2024-12-31 11674155 ns14:PoundSterling 2024-01-01 2024-12-31 11674155 ns10:Director1 2024-01-01 2024-12-31 11674155 ns10:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11674155 ns10:SmallEntities 2024-01-01 2024-12-31 11674155 ns10:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 11674155 ns10:SmallCompaniesRegimeForDirectorsReport 2024-01-01 2024-12-31 11674155 ns10:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11674155 ns10:FullAccounts 2024-01-01 2024-12-31 11674155 1 2024-01-01 2024-12-31 11674155 ns10:OrdinaryShareClass2 2024-01-01 2024-12-31 11674155 ns10:OrdinaryShareClass3 2024-01-01 2024-12-31 11674155 ns10:Director1 41 2023-12-31 11674155 ns10:Director1 41 2022-12-31 11674155 ns10:Director1 41 2024-01-01 2024-12-31 11674155 ns10:Director1 41 2023-01-01 2023-12-31 11674155 ns10:Director1 41 2024-12-31 11674155 ns10:Director1 41 2023-12-31 11674155 ns10:Director2 2024-01-01 2024-12-31 11674155 ns10:RegisteredOffice 2024-01-01 2024-12-31 11674155 ns5:CurrentFinancialInstruments 2024-12-31 11674155 ns5:CurrentFinancialInstruments 2023-12-31 11674155 ns5:Non-currentFinancialInstruments 2024-12-31 11674155 ns5:Non-currentFinancialInstruments 2023-12-31 11674155 ns5:ShareCapital 2024-12-31 11674155 ns5:ShareCapital 2023-12-31 11674155 ns5:RetainedEarningsAccumulatedLosses 2024-12-31 11674155 ns5:RetainedEarningsAccumulatedLosses 2023-12-31 11674155 ns5:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31 11674155 ns5:ComputerSoftware 2024-01-01 2024-12-31 11674155 ns5:LeaseholdImprovements 2024-01-01 2024-12-31 11674155 ns5:PlantMachinery 2024-01-01 2024-12-31 11674155 ns5:FurnitureFittings 2024-01-01 2024-12-31 11674155 ns5:ComputerEquipment 2024-01-01 2024-12-31 11674155 ns5:ComputerSoftware 2023-12-31 11674155 ns5:ComputerSoftware 2024-12-31 11674155 ns5:ComputerSoftware 2023-12-31 11674155 ns5:LeaseholdImprovements 2023-12-31 11674155 ns5:PlantMachinery 2023-12-31 11674155 ns5:FurnitureFittings 2023-12-31 11674155 ns5:ComputerEquipment 2023-12-31 11674155 ns5:LeaseholdImprovements 2024-12-31 11674155 ns5:PlantMachinery 2024-12-31 11674155 ns5:FurnitureFittings 2024-12-31 11674155 ns5:ComputerEquipment 2024-12-31 11674155 ns5:LeaseholdImprovements 2023-12-31 11674155 ns5:PlantMachinery 2023-12-31 11674155 ns5:FurnitureFittings 2023-12-31 11674155 ns5:ComputerEquipment 2023-12-31 11674155 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-12-31 11674155 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2023-12-31 11674155 ns5:AfterOneYear ns5:Non-currentFinancialInstruments 2024-12-31 11674155 ns5:AfterOneYear ns5:Non-currentFinancialInstruments 2023-12-31 11674155 ns5:WithinOneYear 2024-12-31 11674155 ns5:WithinOneYear 2023-12-31 11674155 ns5:BetweenOneFiveYears 2024-12-31 11674155 ns5:BetweenOneFiveYears 2023-12-31 11674155 ns5:AllPeriods 2024-12-31 11674155 ns5:AllPeriods 2023-12-31 11674155 ns5:DeferredTaxation 2023-12-31 11674155 ns5:DeferredTaxation 2024-01-01 2024-12-31 11674155 ns5:DeferredTaxation 2024-12-31 11674155 ns10:OrdinaryShareClass2 2024-12-31 11674155 ns10:OrdinaryShareClass3 2024-12-31 11674155 2 ns10:Director2 2023-12-31 11674155 2 ns10:Director2 2022-12-31 11674155 2 ns10:Director2 2024-01-01 2024-12-31 11674155 2 ns10:Director2 2023-01-01 2023-12-31 11674155 2 ns10:Director2 2024-12-31 11674155 2 ns10:Director2 2023-12-31

REGISTERED NUMBER: 11674155 (England and Wales)

| Unaudited Financial Statements |

| for the Year Ended 31 December 2024 |

| for |

| NEWTON SCIENCE LIMITED |

| NEWTON SCIENCE LIMITED (REGISTERED NUMBER: 11674155) |

Contents of the Financial Statements

for the year ended 31 December 2024

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| NEWTON SCIENCE LIMITED |

Company Information

for the year ended 31 December 2024

| Directors: | Mr J Robson

| Mr L J Millar

| Registered office: | Unit 1

| Swift Business Park

| Creek Way

| Rainham

| Essex

| RM13 8LE

| Registered number: | 11674155 (England and Wales)

| Accountants: | Cooper Parry Advisory Limited

| Broadwalk House, 5th Floor

| 5 Appold Street

| Broadgate

| London

| EC2A 2AG

| NEWTON SCIENCE LIMITED (REGISTERED NUMBER: 11674155) |

Balance Sheet

31 December 2024

2024 | 2023 |

| Notes | £ | £ | £ | £

Fixed assets

Intangible assets | 4 | 111 |  | 291 |  |

Tangible assets | 5 | 21,073 |  | 24,014 |  |

21,184 |  | 24,305 |  |

Current assets

Stocks | 76,590 |  | 96,596 |  |

Debtors | 6 | 91,444 |  | 88,784 |  |

Cash at bank | 8,387 |  | 4,909 |  |

176,421 |  | 190,289 |  |

Creditors

Amounts falling due within one year | 7 | 265,494 |  | 230,917 |  |

Net current liabilities | (89,073 | ) | (40,628 | ) |

Total assets less current liabilities | (67,889 | ) | (16,323 | ) |

Creditors

Amounts falling due after more than one year | 8 | 31,990 |  | 39,232 |  |

Net liabilities | (99,879 | ) | (55,555 | ) |

Capital and reserves

Called up share capital | 11 | 100 |  | 100 |  |

Retained earnings | (99,979 | ) | (55,655 | ) |

Shareholders' funds | (99,879 | ) | (55,555 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

| NEWTON SCIENCE LIMITED (REGISTERED NUMBER: 11674155) |

Balance Sheet - continued

31 December 2024

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 January 2026 and were signed on its behalf by:

Mr L J Millar - Director

| NEWTON SCIENCE LIMITED (REGISTERED NUMBER: 11674155) |

Notes to the Financial Statements

for the year ended 31 December 2024

1. | Statutory information

| Newton Science Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | Accounting policies

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Intangible assets

| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

| Computer software is being amortised evenly over its estimated useful life of five years.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Improvements to property | - | over the length of the lease

| Plant and machinery | - | 10% on cost

| Fixtures and fittings | - | 20% on cost

| Computer equipment | - | 20% on cost

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Financial instruments

| Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

| Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

| Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

| Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

| NEWTON SCIENCE LIMITED (REGISTERED NUMBER: 11674155) |

Notes to the Financial Statements - continued

for the year ended 31 December 2024

2. | Accounting policies - continued

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| Going concern

| Although the company has net liabilities, the director will continue to support the company for the next 12 months, and is confident that the company will be profitable in the future years. The accounts have therefore been prepared on a going concern basis.

3. | Employees and directors

| The average number of employees during the year was 6 (2023 - 6 ) .

| NEWTON SCIENCE LIMITED (REGISTERED NUMBER: 11674155) |

Notes to the Financial Statements - continued

for the year ended 31 December 2024

4. | Intangible fixed assets

Computer |

software |

| £

| Cost

| At 1 January 2024

| and 31 December 2024 | 900 |  |

| Amortisation

| At 1 January 2024 | 609 |  |

| Amortisation for year | 180 |  |

| At 31 December 2024 | 789 |  |

| Net book value

| At 31 December 2024 | 111 |  |

| At 31 December 2023 | 291 |  |

5. | Tangible fixed assets

Fixtures |  |

Improvements | Plant and | and | Computer |  |

to property | machinery | fittings | equipment | Totals |

| £ | £ | £ | £ | £

| Cost

| At 1 January 2024 | 17,628 |  | 18,708 |  | 252 |  | 3,292 |  | 39,880 |  |

| Additions | - |  | 1,523 |  | - |  | - |  | 1,523 |  |

| At 31 December 2024 | 17,628 |  | 20,231 |  | 252 |  | 3,292 |  | 41,403 |  |

| Depreciation

| At 1 January 2024 | 8,014 |  | 5,550 |  | 232 |  | 2,070 |  | 15,866 |  |

| Charge for year | 1,763 |  | 2,023 |  | 20 |  | 658 |  | 4,464 |  |

| At 31 December 2024 | 9,777 |  | 7,573 |  | 252 |  | 2,728 |  | 20,330 |  |

| Net book value

| At 31 December 2024 | 7,851 |  | 12,658 |  | - |  | 564 |  | 21,073 |  |

| At 31 December 2023 | 9,614 |  | 13,158 |  | 20 |  | 1,222 |  | 24,014 |  |

6. | Debtors

2024 | 2023 |

| £ | £

| Amounts falling due within one year:

| Trade debtors | 6,852 |  | 24,147 |  |

| Other debtors | 84,592 |  | 64,592 |  |

91,444 |  | 88,739 |  |

| Amounts falling due after more than one year:

| Other debtors | - |  | 45 |  |

| Aggregate amounts | 91,444 |  | 88,784 |  |

| NEWTON SCIENCE LIMITED (REGISTERED NUMBER: 11674155) |

Notes to the Financial Statements - continued

for the year ended 31 December 2024

7. | Creditors: amounts falling due within one year |

2024 | 2023 |

| £ | £

| Bank loans and overdrafts | 7,243 |  | 7,243 |  |

| Trade creditors | 218,417 |  | 171,317 |  |

| Taxation and social security | 16,674 |  | 12,075 |  |

| Other creditors | 23,160 |  | 40,282 |  |

265,494 |  | 230,917 |  |

8. | Creditors: amounts falling due after more than one year |

2024 | 2023 |

| £ | £

| Bank loans | 31,989 |  | 39,232 |  |

| Other creditors | 1 |  | - |  |

31,990 |  | 39,232 |  |

| Amounts falling due in more than five years:

| Repayable by instalments

| Bank loans more 5 yr by instal | 3,018 |  | 10,261 |  |

9. | Leasing agreements

| Minimum lease payments under non-cancellable operating leases fall due as follows:

2024 | 2023 |

| £ | £

| Within one year | 54,000 |  | 40,000 |  |

| Between one and five years | 229,500 |  | 170,000 |  |

283,500 |  | 210,000 |  |

10. | Deferred tax

| £

| Balance at 1 January 2024 | (3,703 | ) |

| Provided during year | (1,565 | ) |

| Balance at 31 December 2024 | (5,268 | ) |

11. | Called up share capital

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2024 | 2023 |

value: |  | £ | £

| 50 | Ordinary A | £1 | 50 |  | 50 |  |

| 50 | Ordinary B | £1 | 50 |  | 50 |  |

100 |  | 100 |  |

| NEWTON SCIENCE LIMITED (REGISTERED NUMBER: 11674155) |

Notes to the Financial Statements - continued

for the year ended 31 December 2024

12. | Directors' advances, credits and guarantees

| The following advances and credits to directors subsisted during the years ended 31 December 2024 and 31 December 2023:

2024 | 2023 |

| £ | £

| Mr J Robson and Mr L J Millar

| Balance outstanding at start of year | 15,111 |  | (3,518 | ) |

| Amounts advanced | 26,668 |  | 115,799 |  |

| Amounts repaid | (16,903 | ) | (97,170 | ) |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | 24,876 |  | 15,111 |  |

| Amounts advanced to the directors by the company are subject to interest payable at a rate of 2.25% (2024 - 2.5%), and are repayable upon demand.